Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Longevity Acquisition Corp (LOAC)

Longevity Acquisition Corp (LOAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,314
  • Shares Outstanding, K 2,626
  • Annual Sales, $ 0 K
  • Annual Income, $ -290 K
  • 60-Month Beta 0.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.06
Trade LOAC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.28
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 04/29/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.04 +21.83%
on 03/04/21
14.30 -5.94%
on 02/22/21
-0.72 (-5.08%)
since 02/19/21
3-Month
10.63 +26.53%
on 01/27/21
19.25 -30.13%
on 12/28/20
+2.57 (+23.62%)
since 12/18/20
52-Week
10.24 +31.35%
on 12/04/20
19.25 -30.13%
on 12/28/20
+3.05 (+29.33%)
since 03/18/20

Most Recent Stories

More News
4D pharma Announces Completion of Merger With Longevity Acquisition Corporation

4D pharma plc (Nasdaq: LBPS; AIM: DDDD) ("4D pharma" or the "Company"), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D Pharma Announces Private Placement

4D pharma plc (AIM: DDDD) ("4D" or the "Company"), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D Pharma to Present at Upcoming Investor Conferences in March

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announced that 4D management...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D Pharma Appoints John Beck as Chief Financial Officer and Member of the Management Team

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces the appointment of...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D Pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces that the United...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D pharma Announces Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate MRx0518 in Combination with BAVENCIO® for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announced a clinical trial...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D Pharma Presents Update on Oncology Program

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces progress on activities...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SNSS, LOAC, FBSS, and CPAH Mergers

WILMINGTON, Del., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

SNSS : 18.62 (+24.30%)
LOAC : 13.45 (+1.89%)
FBSS : 21.28 (+0.47%)
CPAH : 3.48 (+0.43%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of ELY, LOAC, ROCH, and NGA Mergers

WILMINGTON, Del., Dec. 17, 2020 (GLOBE NEWSWIRE) --

ELY : 21.33 (-2.82%)
LOAC : 13.45 (+1.89%)
ROCH : 28.90 (+12.23%)
NGA : 16.17 (-6.53%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Longevity Acquisition Corporation Merger

WILMINGTON, Del., Dec. 02, 2020 (GLOBE NEWSWIRE) --

LOAC : 13.45 (+1.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 14.22
2nd Resistance Point 13.88
1st Resistance Point 13.67
Last Price 13.45
1st Support Level 13.12
2nd Support Level 12.78
3rd Support Level 12.57

See More

52-Week High 19.25
Fibonacci 61.8% 15.81
Fibonacci 50% 14.74
Fibonacci 38.2% 13.68
Last Price 13.45
52-Week Low 10.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar